Azenta, Inc. (NASDAQ:AZTA) Director William L. Cornog Acquires 12,500 Shares

Azenta, Inc. (NASDAQ:AZTA) Director William L. Cornog bought 12,500 shares of the stock in a transaction on Monday, November 18th. The stock was purchased at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the purchase, the director now directly owns 14,755 shares in the company, valued at approximately $584,298. This represents a 554.32 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Azenta Stock Performance

Azenta stock opened at $40.91 on Wednesday. The firm’s fifty day moving average price is $45.34 and its 200-day moving average price is $50.26. The stock has a market cap of $2.00 billion, a P/E ratio of -13.77 and a beta of 1.48. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million for the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the company posted $0.13 EPS. On average, analysts predict that Azenta, Inc. will post 0.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AZTA has been the topic of several recent analyst reports. Evercore ISI lowered their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC lowered their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $63.60.

Hedge Funds Weigh In On Azenta

A number of large investors have recently added to or reduced their stakes in AZTA. Janney Montgomery Scott LLC raised its position in Azenta by 9.3% in the 1st quarter. Janney Montgomery Scott LLC now owns 5,167 shares of the company’s stock worth $311,000 after purchasing an additional 438 shares during the period. Russell Investments Group Ltd. raised its position in Azenta by 9.5% in the 1st quarter. Russell Investments Group Ltd. now owns 4,698 shares of the company’s stock worth $283,000 after purchasing an additional 409 shares during the period. State Board of Administration of Florida Retirement System raised its position in Azenta by 6.8% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 74,608 shares of the company’s stock worth $4,497,000 after purchasing an additional 4,739 shares during the period. Acadian Asset Management LLC raised its position in Azenta by 24.7% in the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after purchasing an additional 471 shares during the period. Finally, Natixis purchased a new position in Azenta in the 1st quarter worth $151,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.